Biotech spin-off producing mycoprotein for sustainable food.
| Date | Round | Amount |
|---|---|---|
| May 2024 | Funding round Espoo mycoprotein company Enifer secured €36M (equity, loans and a Business Finland grant) to build a factory producing fungi-based protein. | $38.9M |
| May 2024 | Series B Enifer raised a €15M Series B equity round led by Taaleri Bioindustry Fund I, part of a €36M funding package, to build a first-of-its-kind mycoprotein factory. | $16.1M |
| Jan 2024 | Grant Finnish biotech Enifer secured a €12M EU NextGenerationEU grant to build its first commercial PEKILO mycoprotein factory. | $13M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.